{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:58:34Z","timestamp":1791910714433,"version":"4.3.4"},"reference-count":34,"publisher":"BMJ","issue":"7","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child"],"published-print":{"date-parts":[[2015,7]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>We aimed to describe administration of eight potentially harmful excipients of interest (EOI)\u2014parabens, polysorbate 80, propylene glycol, benzoates, saccharin sodium, sorbitol, ethanol and benzalkonium chloride\u2014to hospitalised neonates in Europe and to identify risk factors for exposure.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>All medicines administered to neonates during 1 day with individual prescription and demographic data were registered in a web-based point prevalence study. Excipients were identified from the Summaries of Product Characteristics. Determinants of EOI administration (geographical region, gestational age (GA), active pharmaceutical ingredient, unit level and hospital teaching status) were identified using multivariable logistical regression analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Overall 89 neonatal units from 21 countries participated. Altogether 2095 prescriptions for 530 products administered to 726 neonates were recorded. EOI were found in 638 (31%) prescriptions and were administered to 456 (63%) neonates through a relatively small number of products (n=142; 27%). Parabens, found in 71 (13%) products administered to 313 (43%) neonates, were used most frequently. EOI administration varied by geographical region, GA and route of administration. Geographical region remained a significant determinant of the use of parabens, polysorbate 80, propylene glycol and saccharin sodium after adjustment for the potential covariates including anatomical therapeutic chemical class of the active ingredient.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>European neonates receive a number of potentially harmful pharmaceutical excipients. Regional differences in EOI administration suggest that EOI-free products are available and provide the potential for substitution to avoid side effects of some excipients.<\/jats:p><\/jats:sec>","DOI":"10.1136\/archdischild-2014-307793","type":"journal-article","created":{"date-parts":[[2015,4,9]],"date-time":"2015-04-09T01:52:07Z","timestamp":1428544327000},"page":"694-699","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":70,"title":["Potentially harmful excipients in neonatal medicines: a pan-European observational study"],"prefix":"10.1136","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3897-5482","authenticated-orcid":false,"given":"Georgi","family":"Nellis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuuli","family":"Metsvaht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heili","family":"Varendi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolin","family":"Toompere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Lass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge","family":"Mesek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J","family":"Nunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irja","family":"Lutsar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2015,4,8]]},"reference":[{"key":"key-10.1136\/archdischild-2014-307793-1","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.phrs.2011.01.006","article-title":"Paediatric pharmacology: remember the excipients","volume":"63","author":"Fabiano","year":"2011","journal-title":"Pharmacol Res"},{"key":"key-10.1136\/archdischild-2014-307793-2","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/BF03259937","article-title":"Pharmaceutical Excipients","volume":"3","author":"Golightly","year":"2012","journal-title":"Med Toxicol Adverse Drug Exp"},{"key":"key-10.1136\/archdischild-2014-307793-3","first-page":"72","article-title":"Regulatory Update: The IPEC Novel Excipient Safety Evaluation Procedure","volume":"33","author":"DeMerlis","year":"2009","journal-title":"Pharm Technol"},{"key":"key-10.1136\/archdischild-2014-307793-4","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0014-827X(03)00079-X","article-title":"The safety of pharmaceutical excipients","volume":"58","author":"Pifferi","year":"2003","journal-title":"Farm"},{"key":"key-10.1136\/archdischild-2014-307793-5","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1365-2125.2012.04312.x","article-title":"Developmental pharmacokinetics of propylene glycol in preterm and term neonates","volume":"75","author":"De Cock","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"key-10.1136\/archdischild-2014-307793-6","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/clinchem\/32.5.721","article-title":"Drug use in the neonate: interrelationships of pharmacokinetics, toxicity, and biochemical maturity","volume":"32","author":"Warner","year":"1986","journal-title":"Clin Chem"},{"key":"key-10.1136\/archdischild-2014-307793-7","unstructured":"European Medicines Agency. Guideline on pharmaceutical development of medicines for paediatric use. 2013:1\u201324. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2013\/07\/WC500147002.pdf"},{"key":"key-10.1136\/archdischild-2014-307793-8","unstructured":"European Medicines Agency. Guideline on the investigation of medicinal products in the term and preterm neonate. 2009:1\u201321. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/09\/WC500003754.pdf"},{"key":"key-10.1136\/archdischild-2014-307793-9","volume-title":"Handbook of pharmaceutical excipients","author":"Rowe","year":"2012","edition":"7"},{"key":"key-10.1136\/archdischild-2014-307793-10","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ejpb.2010.06.008","article-title":"Commonly used nonionic surfactants interact differently with the human efflux transporters ABCB1 (p-glycoprotein) and ABCC2 (MRP2)","volume":"76","author":"Hanke","year":"2010","journal-title":"Eur J Pharm Biopharm"},{"key":"key-10.1136\/archdischild-2014-307793-11","author":"European Commission","year":"2003","journal-title":"Excipients in the label and package leaflet of medicinal products for human use"},{"key":"key-10.1136\/archdischild-2014-307793-12","doi-asserted-by":"crossref","first-page":"F392","DOI":"10.1136\/adc.2009.160192","article-title":"Safety of \u201cinert\u201d additives or excipients in paediatric medicines","volume":"94","author":"Nahata","year":"2009","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"key-10.1136\/archdischild-2014-307793-13","unstructured":"European Medicines Agency. Questions & answers on propylene glycol and esters in the context of the revision of the guideline on \u201c Excipients in the label and package leaflet of medicinal products for human use\u201d (CPMP\/463\/00). 2014. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2014\/12\/WC500177945.pdf"},{"key":"key-10.1136\/archdischild-2014-307793-14","unstructured":"European Medicines Agency. Reflection paper: formulations of choice for the paediatric population. Published Online First: 2006. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/09\/WC500003782.pdf (accessed 11 Dec2012)."},{"key":"key-10.1136\/archdischild-2014-307793-15","unstructured":"European Medicines Agency. Questions and Answers on Ethanol in the context of the revision of the guideline on \u201cExcipients in the label and package leaflet of medicinal products for human use\u201d (CPMP\/463\/00) Draft. 2014. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2014\/02\/WC500162033.pdf"},{"key":"key-10.1136\/archdischild-2014-307793-16","unstructured":"European Medicines Agency. Reflection paper on the use of methyl- and propylparaben as excipients in human medicinal products for oral use. 2013:1\u201311. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2013\/05\/WC500143139.pdf"},{"key":"key-10.1136\/archdischild-2014-307793-17","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1542\/peds.77.4.500","article-title":"Benzyl alcohol toxicity: impact on mortality and intraventricular hemorrhage among very low birth weight infants","volume":"77","author":"Hiller","year":"1986","journal-title":"Pediatrics"},{"key":"key-10.1136\/archdischild-2014-307793-18","unstructured":"European Medicines Agency. Questions and Answers on Benzoic acid and Benzoates in the context of the revision of the guideline on \u201c Excipients in the label and package leaflet of medicinal products for human use\u201d (CPMP\/463\/00). 2014. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2014\/02\/WC500162031.pdf"},{"key":"key-10.1136\/archdischild-2014-307793-19","unstructured":"European Medicines Agency. Questions and Answers on Benzyl alcohol in the context of the revision of the guideline on \u201c Excipients in the label and package leaflet of medicinal products for human use \u201c (CPMP\/463\/00). 2014. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2014\/02\/WC500162032.pdf"},{"key":"key-10.1136\/archdischild-2014-307793-20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.yrtph.2011.02.010","article-title":"Excipients in medicinal products used in gastroenterology as a possible cause of side effects","volume":"60","author":"Ursino","year":"2011","journal-title":"Regul Toxicol Pharmacol"},{"key":"key-10.1136\/archdischild-2014-307793-21","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1542\/peds.109.5.797","article-title":"Association between infantile colic and carbohydrate malabsorption from fruit juices in infancy","volume":"109","author":"Duro","year":"2002","journal-title":"Pediatrics"},{"key":"key-10.1136\/archdischild-2014-307793-22","doi-asserted-by":"crossref","first-page":"F236","DOI":"10.1136\/adc.2008.146035","article-title":"Toxic additives in medication for preterm infants","volume":"94","author":"Whittaker","year":"2009","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"key-10.1136\/archdischild-2014-307793-23","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/PCC.0b013e31819a383c","article-title":"Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates","volume":"10","author":"Shehab","year":"2009","journal-title":"Pediatr Crit care Med"},{"key":"key-10.1136\/archdischild-2014-307793-24","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/1471-2431-12-136","article-title":"Hospitalised neonates in Estonia commonly receive potentially harmful excipients","volume":"12","author":"Lass","year":"2012","journal-title":"BMC Pediatr"},{"key":"key-10.1136\/archdischild-2014-307793-25","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00431-014-2272-z","article-title":"Toxic excipients in medications for neonates in Brazil","volume":"173","author":"Souza","year":"2014","journal-title":"Eur J Pediatr"},{"key":"key-10.1136\/archdischild-2014-307793-26","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1471-2288-14-89","article-title":"Comparison of two alternative study designs in assessment of medicines utilisation in neonates","volume":"14","author":"Nellis","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"key-10.1136\/archdischild-2014-307793-27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.addr.2013.11.003","article-title":"Risk assessment of neonatal excipient exposure: Lessons from food safety and other areas","volume":"73C","author":"Turner","year":"2014","journal-title":"Adv Drug Deliv Rev"},{"key":"key-10.1136\/archdischild-2014-307793-28","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1542\/peds.2004-1697","article-title":"Levels of neonatal care","volume":"114","author":"Stark","year":"2004","journal-title":"Pediatrics"},{"key":"key-10.1136\/archdischild-2014-307793-29","volume-title":"Categories of Care 2011","author":"Modi","year":"2011"},{"key":"key-10.1136\/archdischild-2014-307793-30","unstructured":"United Nations Statistics Division\u2014composition of macro geographical (continental) regions, geographical sub-regions, and selected economic and other groupings. 2012. http:\/\/unstats.un.org\/unsd\/methods\/m49\/m49regin.htm#europe (accessed 13 Dec 2012)."},{"key":"key-10.1136\/archdischild-2014-307793-31","unstructured":"WHO | Preterm birth. 2013. http:\/\/www.who.int\/mediacentre\/factsheets\/fs363\/en\/ (accessed 19 Dec 2013)."},{"key":"key-10.1136\/archdischild-2014-307793-32","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.addr.2014.02.012","article-title":"Playing hide and seek with poorly tasting paediatric medicines: do not forget the excipients","volume":"73","author":"Walsh","year":"2014","journal-title":"Adv Drug Deliv Rev"},{"key":"key-10.1136\/archdischild-2014-307793-33","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1007\/s11095-014-1520-2","article-title":"An observational study of blood concentrations and kinetics of methyl- and propyl-parabens in neonates","volume":"32","author":"Mulla","year":"2015","journal-title":"Pharm Res"},{"key":"key-10.1136\/archdischild-2014-307793-34","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ijpharm.2013.09.013","article-title":"The STEP (Safety and Toxicity of Excipients for Paediatrics) database: Part 2\u2014The pilot version","volume":"457","author":"Salunke","year":"2013","journal-title":"Int J Pharm"}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2014-307793","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T18:23:12Z","timestamp":1651688592000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/archdischild-2014-307793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,8]]},"references-count":34,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,6,19]]},"published-print":{"date-parts":[[2015,7]]}},"alternative-id":["10.1136\/archdischild-2014-307793"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2014-307793","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"value":"0003-9888","type":"print"},{"value":"1468-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,8]]}}}